XML 15 R46.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
6 Months Ended 12 Months Ended 2 Months Ended 6 Months Ended 12 Months Ended 6 Months Ended 12 Months Ended 6 Months Ended 3 Months Ended
Mar. 31, 2013
Cash performance unit awards
Sep. 30, 2012
Cash performance unit awards
Sep. 30, 2010
Cash performance unit awards
Sep. 30, 2012
Cash performance unit awards - 2012 grants
Sep. 30, 2011
Cash performance unit awards - 2012 grants
Mar. 31, 2013
Cash performance unit awards - 2012 grants
Sep. 30, 2014
Cash performance unit awards - 2012 grants
Sep. 30, 2013
Cash performance unit awards - 2012 grants
Mar. 31, 2013
Cash performance unit awards - 2013 grants
Mar. 31, 2013
SARs - 2011 Awards
Sep. 30, 2011
SARs - 2011 Awards
Mar. 31, 2013
SARs - 2012 Awards
Mar. 31, 2013
Minimum
SARs - 2012 Awards
Commitments and Contingencies                          
Performance period     5 years                    
Amount of cash flow performance goals     $ 850.0                    
Amount of cash flow achieved   319.2                      
Amount of cash flow expenses accrued   4.0                      
Additional expense expected to be recognized during the year under the amended performance unit awards 1.4                        
Expense recognized under the amended performance unit awards 0.3                        
Percentage of performance units vested             50.00% 50.00%          
Average stock price period       60 days 60 days             60 days  
Amount recorded for performance unit award grants           9.6     0        
Grants approved by committee to employees for cash settled stock appreciation rights (in shares)                     0.4 1.0  
Grants approved by committee to employees for cash settled stock appreciation rights outstanding (in shares)                   0.2   0.9  
Amount accrued for awards                   $ 1.6   $ 5.5  
Grant-date stock price (in dollars per share)                     $ 3.81 $ 1.85  
Percentage of stock price on grant date                         135.00%
Threshold stock price at which SARS will vest (in dollars per share)                         $ 2.50